Saturday 17 October 2026 Export URGN’s income statement to Excel — free account

Urogen Pharma

Urogen Pharma’s revenue for fiscal 2025 (year ended December 2025) was $109.8 million, up 21.4% from fiscal 2024. In the quarter to June 2026, revenue grew 199.2%, EPS grew 73.3%, free cash flow grew 17.3% and total debt rose 56.5%, each against the same quarter a year earlier. Revenue growth for five consecutive years.

34.56 2.05 −5.60%

Follow URGN

Alert me

Market cap: $1.8B
P/E: 0.0×
Fwd P/E: −30.0×
Dividend yield: —
F-score: 2/9
Altman Z: −5.16
Beneish M: −1.42
Dividend safety: n/a

Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

	Jun '26	Mar '26	Dec '25	Sep '25	Older periods
P/E ratio Full definition →	0.00	0.00	0.00	0.00	+8 more quarters Free account
P/S ratio Full definition →	9.82	6.42	10.26	9.93
P/FCF ratio Full definition →	0.00	0.00	0.00	0.00
P/Operating CF Full definition →	(56.17)	(19.91)	(29.40)	(22.68)
P/B ratio Full definition →	0.00	0.00	0.00	0.00
Price to Tangible BV Full definition →	0.00	0.00	0.00	0.00
EV/Sales Full definition →	10.26	6.76	10.30	9.87
EV/EBITDA Full definition →	0.00	0.00	0.00	0.00
EV/Operating CF Full definition →	(12.18)	(5.73)	(6.96)	(6.92)
EV/FCF Full definition →	(12.17)	(5.72)	(6.95)	(6.90)
Quick Ratio Full definition →	3.20	3.89	3.34	3.51
Current Ratio Full definition →	3.80	4.69	4.01	3.99
Net Debt/EBITDA Full definition →	505.33	(2.38)	(0.20)	0.22
Debt/Assets Full definition →	75.88%	74.71%	62.70%	65.99%
Debt/Equity Full definition →	(1.45)	(1.53)	(1.19)	(1.06)
Asset Turnover Full definition →	0.82	0.56	0.45	0.40
Operating CF/Net income Full definition →	2.30	1.92	1.45	1.27
Capex/Depreciation Full definition →	(1.15)	(0.53)	0.00	0.05
Interest Coverage Full definition →	0.02	(4.84)	(5.07)	(8.12)
Research and Development Expense of Revenue Full definition →	23.93%	30.61%	37.83%	50.97%
Selling, General and Administrative Expense of Revenue Full definition →	66.85%	101.03%	104.00%	136.75%
Intangible Assets out of Total Assets Full definition →	0.00	0.00	0.00	0.00
Share Based Compensation of Revenue Full definition →	7.36%	9.08%	8.27%	11.01%
Graham Net Nets Full definition →	(0.08)	(0.16)	(0.11)	(0.14)
Graham Number Full definition →	10.82	12.38	12.56	13.67
Earnings Yield Full definition →	(5.38%)	(15.29%)	(13.66%)	(17.34%)
Free Cash Flow Yield Full definition →	(8.58%)	(18.40%)	(14.44%)	(14.41%)
Revenue per Share Full definition →	1.44	1.02	0.79	0.57
Operating CF per Share Full definition →	(0.66)	(0.90)	(0.80)	(0.88)
Capex per Share Full definition →	0.00	0.00	0.00	0.00
Free Cash Flow per Share Full definition →	(0.66)	(0.90)	(0.80)	(0.88)
Cash per Share Full definition →	2.17	2.82	2.53	2.67
Shareholders Equity per Share Full definition →	(2.63)	(2.48)	(2.19)	(2.40)
Interest Debt per Share Full definition →	0.00	0.00	0.00	0.00
Book value per Share Full definition →	(2.63)	(2.48)	(2.19)	(2.40)
Free Cash Flow Full definition →	(33.07)	(45.37)	(38.34)	(42.36)
Working Capital Full definition →	173.51	186.83	139.61	126.30
Capital Expenditures Full definition →	(0.06)	(0.05)	(0.02)	(0.09)
Net Current Asset Value Full definition →	(149.56)	(140.48)	(119.90)	(131.91)
EV/EBIT Full definition →	0.00	0.00	0.00	0.00
Capex to Sales Full definition →	0.00	0.00	0.00	0.00
Price to Operating Income Full definition →	0.00	0.00	0.00	0.00
Other line items
Average Receivables Full definition →	54.20	37.53	26.69	21.25
Average Payables Full definition →	35.45	32.83	27.57	22.93
Average Inventory Full definition →	15.86	14.26	12.85	7.97
Average Assets Full definition →	230.65	250.65	243.08	243.49
Average Common Equity Full definition →	(112.89)	(85.36)	(57.14)	(44.95)

Fold the line items

Columns are period end dates

Stockrow Weekly